Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2016
Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorderSvetlana Hakobyan, Sebastian Luppe, David Rs Evans, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|June 7, 2018
Safety profile of an 8F femoral arteriotomy closure using the Angio-Seal device in thrombolysed acute stroke patients undergoing thrombectomyJames Wareham, Sebastian Luppe, Adam Youssef, et al.
Expert Opinion on Drug Safety|June 18, 2014
Drug safety evaluation of alemtuzumab for multiple sclerosisMark Willis, Neil P Robertson
Current Neurology and Neuroscience Reports|August 4, 2016
Alemtuzumab for Multiple SclerosisMark D Willis, Neil P Robertson
Current Opinion in Allergy and Clinical Immunology|October 10, 2018
Secondary antibody deficiency in neurologyEmma C Tallantyre, Neil P Robertson, Stephen Jolles
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2009
Clinical and genetic characteristics of non-Asian dentatorubral-pallidoluysian atrophy: A systematic reviewMark Wardle, Huw R Morris, Neil P Robertson
Journal of Neuroimmunology|April 23, 2010
Elevated plasma C4a levels in multiple sclerosis correlate with disease activityGillian Ingram, Svetlana Hakobyan, Neil P Robertson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2012
Temporal evolution of remission following multiple sclerosis relapse and predictors of outcomeClaire L Hirst, Gillian Ingram, Trevor P Pickersgill, et al.
Pageof 7